Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
593K
-
Shares change
-
-56.2M
-
Total reported value, excl. options
-
$13.8M
-
Value change
-
-$8.4B
-
Number of buys
-
1
-
Number of sells
-
-215
-
Price
-
$13.88
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q4 2022
240 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q4 2022.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 593K shares
.
Largest 10 shareholders include Knoll Capital Management, LLC (450K shares), Liontrust Investment Partners LLP (135K shares), Birchview Capital, LP (7.37K shares), FNY Investment Advisers, LLC (250 shares), Ronald Blue Trust, Inc. (65 shares), McElhenny Sheffield Capital Management, LLC (31 shares), IFP Advisors, Inc (1 shares), WELLS FARGO & COMPANY/MN (0 shares), BROWN BROTHERS HARRIMAN & CO (0 shares), and PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.